The global pet DNA testing market size is estimated to reach USD 322.02 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.20% over the forecast period. The market growth is propelled by factors, such as increasing pet adoption rates, rising consumer genomics, increasing R&D activities by key companies & academic researchers, and growing awareness & sales of pet DNA testing kits. Furthermore, recent pet humanization trends have made pet parents increasingly willing to spend more money on pet care to protect or extend the life of their beloved cats and dogs.
For instance, according to FEDIAF 2022 report, pet-related products and services sales accounted for USD 24.5 billion in 2021, which significantly increased from the previous year. As the field of genomics is advancing in the veterinary industry, pet genetic test kits are becoming more common. Companies are offering at-home dog & cat DNA testing resources for breeders, pet owners, and veterinarians for over 15 years. Since the introduction of direct-to-consumer genetic test products in 2009 by Mars Petcare, the market has been significantly growing with considerable opportunities. Similar to the widening scope of human genomics and genetic testing, DNA profiling procedures in veterinary industries are growing.
With regard to the accuracy, at-home DNA sampling tests for pets have proven to be reliable with enormous valuable information. For example, Embark Veterinary, Inc. states that its breed profile tests are over 95% accurate. Some breeds, such as Labradors, have always gained the top spot among Americans owing to their friendliness, versatility & athleticism, stable temperament, and ability to be easily trained. Therefore, pet owners are greatly concerned about the mixes of breeds in pets before adopting. This enables professional breeders to produce puppies as per the specific requirements of their customers. Pet DNA test kits allow them to specifically select animals with certain breed histories and prevent disease-risk puppies.
With growing interest among people to understand the ancestral traits of animals and their ages to celebrate birthdays, the market has significant growth opportunities. Key players are planning to add more tests for several other genetic conditions and are collaborating & partnering with pet insurance companies trying to enhance the scope of insurance in the market.The COVID-19 pandemic resulted in significant growth of the pet industry by setting new trends. In times of quarantine and fear, having companion animals was a widely opted choice among Americans, which set the fast phase of the booming pet industry growth that will sustain for the following several years.
According to the American Society for the Prevention of Cruelty to Animals (ASPCA), over 23 million American households adopted a new pet during the pandemic. Although this factor significantly boosted market opportunities, the supply chain disruption, movement restrictions, and COVID positive situations in households coupled with fewer breed tests conducted during 2020 had a mildly negative impact on the industry growth. However, major players were continuously active during the pandemic with the implementation of several safety measures.
The dogs segment dominated the global industryin 2022 and accounted for the largest share of over 70% the overall revenue. The adoption of pets, especially dogs, is significantly increasing among the American population. According to the National Pet Owners Survey 2021-2022 conducted by the American Pet Products Association, 69 million households (around 54%) in the U.S. owned dogs, which increased from 50% of households registered in 2018. Dogs have maintained significant status and popularity in North America for decades, with people often treating them as loyal family members. To a degree, where one-third of the U.S. population loves their dogs more than their partners.
Cats are the second-most popular pet choice. This segment is driven by growing trends of adopting cats over dogs owing to their calm nature with excellent memory & learning capabilities. Cats are often considered to be low-maintenance pets as they do not require training for basic self-cleaning. Younger generations, especially millennials, have become more attracted to cats with around 45.3 million households in the U.S. owning cats in 2021 according to the American Pet Products Association. So far, over 250 hereditary diseases have been discovered in cats, and understanding their breed history will be key in curing such diseases with timely treatments. Recent studies denote that cat DNA test reveals that some feline population has lived alongside humans for over 3000 years.
On the basis of sample types, the industry is classified into blood, saliva, semen, and others. The saliva segment led the industry in 2022 and accounted for the maximum share of 58.00% of the overall revenue as most pet DNA tests are performed using saliva or cheek swab samples. The convenience of collecting a saliva sample from a dog’s jowl is much easier than other modes of sample collection. However, as dog saliva contains a good amount of pathogenic agents, they require special preparation before submitting it to the laboratory. For instance, a few DNA test kits mention adding water to mix the animal’s saliva to reduce the risk of sample contamination.
The saliva sample type is also expected to register the fastest CAGR over the forecast period. On the other hand, tests using blood and semen samples are significantly used in specific cases. Pet DNA tests using blood samples are a noninvasive and simple way to identify genetic/inheritable diseases in animals. These tests are usually performed by drawing blood from the veins of animals and securely sharing the collected sample with the specific laboratory. Key players in the industry, such as NeoGen Corp., offer semen sample DNA test kits for dogs known as Canine SNP (Single Nucleotide Polymorphisms) & STR (Short Tandem Repeats) Parentage. This DNA test distinguishes between closely related sires more effectively than conventional tests for STRs, which identify STRs.
The genetic diseases segment dominated the industry in 2022 with a share of over 35.00% of the overall revenue. The health & wellness segment is expected to grow at the fastest CAGR over the forecast period. Some pet breeds are highly prone to inheritable diseases and lower life expectancy rates. Therefore, doing a full genetic attribute profile can determine the appropriate risk of genetic conditions in purebred, mixed-bred, and hybrid pets. In cases where the breed mix of a particular pet is already known for specific disease susceptibility, then individual genetic DNA tests can be performed to diagnose the single concerned medical issue.
Pet owners are interested in understanding certain established personalities and physical traits of their companion animals. By knowing the breeds & mixes, pet parents can easily predict the future size, temperament, color patterns, energy levels, the need for behavior training, and exercise requirements. Thus, the demand for pet DNA test kits is highly registered among pet owners owing to their willingness to promote better preventive care at early stages. Knowing a pet’s genetic makeup and its potential medical condition predisposition will also allow owners, professional pet breeders, or veterinarians to suggest better-tailored diets, preventive healthcare plans, & wellness training.
The breeders end-user segment dominated the industry in 2022 while the pet owners segment is expected to grow at the fastest CAGR of over 9% during the forecast period. Breeders around the world are striving to breed better dog or cat breeds with quality traits for every generation of owners to suit their requirements. Along with physical features, such as attractive fur color, eye color, height, weight, and other traits, owners are now looking for animals with better health and talents in specific tasks. Owing to these factors, breeders are now educating themselves about several breed mixes and possible mating to suit people’s needs.
One such commonly used product for the said application is a pet DNA test kit.Pet ownership has increased greatly in the last decade among households in developed countries, owing to their benefits, such as easing loneliness; relieving anxiety, depression, & stress; health & mood-boosting capabilities; and providing unconditional love. In the U.S., millennials are the largest group of pet owners and also the biggest spenders. Pet expenditure in the country has grown significantly over the years, especially for dogs. For instance, according to the American Pet Products Association, U.S. pet parents spent over USD 123 billion for their companion animals in 2021, which increased from USD 90 billion in 2018.
The North American region accounted for the highest revenue share of over 42% in 2022. This share can be attributed to the increasing pet expenditure and a large pet population. In addition, the presence of key players, such as Wisdom Panel (Mars, Inc.); Embark Veterinary, Inc.; Dognomics (Clinomics); Basepaws, Inc. (Zoetis); and NeoGen Corp., is positively influencing the industry growth. For instance, in July 2021, Wisdom Panel (Mars, Inc.) launched Wisdom Panel Dog DNA tests for breed detection.
To determine a puppy’s breed history, the panel provides more than 98% correct results.The Asia Pacific region is anticipated to grow at the fastest CAGR during the forecast period. The rising interest among people in adopting companion animals and the growing disposable income boost the region’s pet care expenditure. In addition, rapid pet care advancement in countries, such as China, India, South Korea, and Japan, is expected to propel regional market growth.
Owing to the significant presence of notable manufacturers, the industry is anticipated to be fairly competitive. Industry participants have undertaken various strategic initiatives, such as partnerships, mergers & acquisitions, sales & marketing activities, product expansion, and product launches, to strengthen their market presence and gain a higher share. Some of the prominent players in the global pet DNA testing market include:
Wisdom Panel (Mars, Inc.)
Orivet Genetic Pet Care Ltd.
Embark Veterinary, Inc.
Dognomics (Clinomics)
DNA MY DOG (Canadian Dog Group Ltd.)
Basepaws, Inc. (Zoetis)
Neogen Corp.
GenSolDiagnostics, LLC
FidoCure (OHC)
PetDx
Report Attribute |
Details |
Market size value in 2023 |
USD 345.69 million |
Revenue forecast in 2030 |
USD 640.24 million |
Growth rate |
CAGR of 9.20% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million/billionand CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Animal type, sample type, test type, end-user, region |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Rest of Europe; Japan; China; India; Australia; South Korea; Rest of APAC; Brazil; Mexico; Rest of LATAM; South Africa; Rest of MEA |
Key companies profiled |
Wisdom Panel (Mars, Inc.); Orivet Genetic Pet Care Ltd.; Embark Veterinary, Inc.; Dognomics (Clinomics); DNA MY DOG (Canadian Dog Group Ltd.); Basepaws, Inc. (Zoetis); Neogen Corp.; GenSolDiagnostics, LLC; FidoCure (OHC); PetDx |
Customization scope |
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional,and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global pet DNA testing market report based on animal type, sample type, test type, end-user, and region:
Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Dogs
Cats
Sample Type Outlook (Revenue, USD Million, 2018 - 2030)
Blood
Saliva
Semen
Others
Test Type Outlook (Revenue, USD Million, 2018 - 2030)
Breed Profile
Genetic Diseases
Health & Wellness
End-user Outlook (Revenue, USD Million, 2018 - 2030)
Pet Owners
Breeders
Veterinarians
Regional Outlook (Revenue, USD Million,2018 - 2030)
North America
U.S.
North-East
New England
Middle Atlantic
Mid-West
East North Central
West North Central
West
Mountain
Pacific
South
South Atlantic
East South Central
West South Central
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Rest of MEA
b. The global pet DNA testing market size was estimated at USD 322.02 Million in 2022 and is expected to reach USD 345.69 Million in 2023.
b. The global pet DNA testing market is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030 to reach USD 640.24 Million by 2030.
b. North American region registered the highest market revenue share of over 42% in 2022. This share can be attributed to the increasing pet expenditure and a large pet population.
b. Some key players operating in the global pet DNA testing market include Wisdom Panel (Mars, Inc.); Orivet Genetic Pet Care Limited; Embark Veterinary, Inc.; Dognomics (Clinomics); DNA MY DOG (Canadian Dog Group Ltd.); Basepaws, Inc. (Zoetis); Neogen Corporation; GENSOL DIAGNOSTICS, LLC; FidoCure (OHC); PetDx, and others.
b. The market growth is propelled by factors such as increasing pet adoption rates, rising consumer genomics, increasing R&D activities by key companies and academic researchers, and growing awareness & sales of pet DNA testing kits.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.